ARTICLE | Clinical News
Beraprost: Completed Phase III study
February 26, 2001 8:00 AM UTC
United Therapeutics Corp. (UTHR), Silver Spring, Md. Product: Beraprost Business: Pulmonary, Cardiovascular Therapeutic category: Vasodilation Target: Pulmonary blood vessels and platelets Descriptio...